Fatty Acid Synthase (FASN) Inhibitors Suppress Metformin-Induced Fat Accumulation and Apoptosis in H4IIE Hepatocellular Carcinoma Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
We previously reported that metformin, a widely prescribed antidiabetic drug, induces the accumulation of triglyceride (TG) together with the apoptotic death of H4IIE via AMPactivated protein kinase (AMPK) in hepatocellular carcinoma (HCC) cells. However, the effect of cytoplasmic fat accumulation on the growth of HCCs remains controversial. Herein, we investigated the effect of fatty acid synthase (FASN) inhibitors on the basal- or metformininduced changes including the content of cytoplasmic TG and the viability of HCC cells. Cerulenin and C75, inhibitors of FASN, did not significantly affect the basal TG content but dose-dependently suppressed the metformin-induced increase in the cytoplasmic TG content. Metformin-induced apoptosis of H4IIE cells was also significantly reduced by cerulenin and C75. Metformin enhanced the generation of reactive oxygen species which was suppressed by adding cerulenin or T75. Cerulenin also stimulated cell migration, which was suppressed by metformin. However, the degree of suppressive effect of metformin on TG synthesis, apoptosis, and cell migration was much more prominent by the inhibition of AMPK by compound C than cerulenin. In conclusion, our study found that excess fat accumulation is responsible for the apoptosis of H4IIE HCC cells and is informative for designing anti-tumor reagents, especially in HCC.
Abstract
We previously reported that metformin, a widely prescribed antidiabetic drug, induces the accumulation of triglyceride (TG) together with the apoptotic death of H4IIE via AMPactivated protein kinase (AMPK) in hepatocellular carcinoma (HCC) cells. However, the effect of cytoplasmic fat accumulation on the growth of HCCs remains controversial. Herein, we investigated the effect of fatty acid synthase (FASN) inhibitors on the basal- or metformininduced changes including the content of cytoplasmic TG and the viability of HCC cells. Cerulenin and C75, inhibitors of FASN, did not significantly affect the basal TG content but dose-dependently suppressed the metformin-induced increase in the cytoplasmic TG content. Metformin-induced apoptosis of H4IIE cells was also significantly reduced by cerulenin and C75. Metformin enhanced the generation of reactive oxygen species which was suppressed by adding cerulenin or T75. Cerulenin also stimulated cell migration, which was suppressed by metformin. However, the degree of suppressive effect of metformin on TG synthesis, apoptosis, and cell migration was much more prominent by the inhibition of AMPK by compound C than cerulenin. In conclusion, our study found that excess fat accumulation is responsible for the apoptosis of H4IIE HCC cells and is informative for designing anti-tumor reagents, especially in HCC.
참고문헌 (38)
- Ackerman D, "Hypoxia, lipids, and cancer : Surviving the harsh tumor microenvironment", Trends Cell Biol, 24, pp.472~478 (2014)
- Alnahdi A, "Augmentation of glucotoxicity, oxidative stress, apoptosis and mitochondrial dysfunction in HepG2 cells by palmitic acid", Nutrients, 11, pp.1979~ (2019)
- Barzilai N, "Metformin as a tool to target aging", Cell Metab, 23, pp.1060~1065 (2016)
- Bi J, "Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling", Cell Metab, 30, pp.525~538.E8 (2019)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Chen LY, "Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN", APP axis as novel therapeutic strategies, 2024, pp.65, 100660~
- Fang F, "Cerulenin induces apoptosis in hepatic cancer HepG2 cells in vitro and in vivo", Int J Clin Exp Med, 12, pp.8334~8341 (2019)
- Fiume L, "Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines", Pharmacology, 86, pp.157~162 (2010)
- Forslund K, "Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota", Nature, 528, pp.262~266 (2015)
- Greenspan P, "Nile red : A selective fluorescent stain for intracellular lipid droplets", J Cell Biol, 100, pp.965~973 (1985)
- Halliwell B, "Measuring reactive species and oxidative damage in vivo and in cell culture : How should you do it and what do the results mean?", Br J Pharmacol, 142, pp.231~255 (2004)
- Hanahan D, "Hallmarks of cancer : The next generation", Cell, 144, pp.646~674 (2011)
- Hayashi T, "Excess glucose alone induces hepatocyte damage due to oxidative stress and endoplasmic reticulum stress", Exp Cell Res, 442, pp.114264~ (2024)
- Ho TS, "Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells", Biomed Pharmacother, 61, pp.578~587 (2007)
- Justus CR, "In vitro cell migration and invasion assays", J Vis Exp, 2014, pp.51046~ (2014)
- Kaji K, "Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake", Int J Cancer, 142, pp.1712~1722 (2018)
- Lee H, "Cancer depends on fatty acids for ATP production : A possible link between cancer and obesity", Semin Cancer Biol, 86, pp.347~357 (2022)
- Lee JS, "ATP production relies on fatty acid oxidation rather than glycolysis in pancreatic ductal adenocarcinoma", Cancers, 12, pp.2477~ (2020)
- Liu X, "Endoplasmic reticulum stress and liver diseases", Liver Res, 3, pp.55~64 (2019)
- Moreadith RW, "The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme", J Biol Chem, 259, pp.6215~6221 (1984)
- Mosmann T, "Rapid colorimetric assay for cellular growth and survival : Application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
- Mota M, "Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease", Metabolism, 65, pp.1049~1061 (2016)
- Park D, "Metformin induces oxidative stress-mediated apoptosis without the blockade of glycolysis in H4IIE hepatocellular carcinoma cells", Biol Pharm Bull, 42, pp.2002~2008 (2019)
- Park D, "Metformin induces lipogenesis and apoptosis in H4IIE hepatocellular carcinoma cells", Dev Reprod, 27, pp.77~89 (2023)
- Park DB, "Metformin promotes apoptosis but suppresses autophagy in glucose-deprived H4IIE hepatocellular carcinoma cells", Diabetes Metab J, 39, pp.518~527 (2015)
- Paul B, "Lipid alterations in chronic liver disease and liver cancer", JHEP Rep, 4, pp.100479~ (2022)
- Piva TJ, "Oxidation of glutamine in HeLa cells : Role and control of truncated TCA cycles in tumour mitochondria", J Cell Biochem, 68, pp.213~225 (1998)
- Rae C, "Cytotoxicity and radiosensitizing activity of the fatty acid synthase inhibitor C75 is enhanced by blocking fatty acid uptake in prostate cancer cells", Adv Radiat Oncol, 5, pp.994~1005 (2020)
- Raez LE, "A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors", Cancer Chemother Pharmacol, 71, pp.523~530 (2013)
- Ramírez-Zacarías JL, "Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O", Histochemistry, 97, pp.493~497 (1992)
- Rena G, "The mechanisms of action of metformin", Diabetologia, 60, pp.1577~1585 (2017)
- Rudalska R, "LXRα activation and Raf inhibition trigger lethal lipotoxicity in liver cancer", Nat Cancer, 2, pp.201~217 (2021)
- Vancura A, "Metformin as an anticancer agent", Trends Pharmacol Sci, 39, pp.867~878 (2018)
- Ward PS, "Metabolic reprogramming : A cancer hallmark even warburg did not anticipate", Cancer Cell, 21, pp.297~308 (2012)
- Yang WS, "Ferroptosis : Death by lipid peroxidation", Trends Cell Biol, 26, pp.165~176 (2016)
- Yin J, "Effects of berberine on glucose metabolism in vitro", Metabolism, 51, pp.1439~1443 (2002)
- Zhang H, "Metformin and reduced risk of hepatocellular carcinoma in diabetic patients : A meta-analysis", Scand J Gastroenterol, 48, pp.78~87 (2013)
- Zhang Y, "Metformin actions on the liver : Protection mechanisms emerging in hepatocytes and immune cells against NASH-related HCC", Int J Mol Sci, 22, pp.5016~ (2021)